Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Strongbridge Biopharma plc (SBBP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Strongbridge Biopharma plc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Strongbridge Biopharma plc historical data, for real-time data please try another search
2.000 +0.000    +0.00%
05/10 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 2.020 / 2.080
  • Day's Range: 1.950 - 2.060
Strongbridge Biopharma plc 2.000 +0.000 +0.00%

Strongbridge Biopharma plc Company Profile

 
Get an in-depth profile of Strongbridge Biopharma plc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

72

Equity Type

ORD

As of October 5, 2021, Strongbridge Biopharma plc was acquired by Xeris Pharmaceuticals, Inc. Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs in the United States. The company offers Keveyis, an oral carbonic anhydrase inhibitor to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis. Its clinical-stage product candidates include Recorlev, a cortisol synthesis inhibitor, which is in Phase III clinical trials for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that has completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is based in Trevose, Pennsylvania.

Contact Information

Address 900 Northbrook Drive Suite 200
Trevose, 19053
United States
Phone 610 254 9200
Fax -
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SBBP Comments

Write your thoughts about Strongbridge Biopharma plc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
신정당대권후보 장필우
신정당대권후보 장필우 Feb 28, 2021 11:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If new drug is approved, it will go up over 30$
Jacint Gabris
Jacint Gabris Feb 28, 2021 11:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
4-5$. maybe.
L. E. M.
L. E. M. Feb 12, 2021 7:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why would there be someone trying to sell 10,000 shares of sbbp at $2.50? When the current price is 3.38?
Jacint Gabris
Jacint Gabris Feb 12, 2021 7:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think, U know the answer. The truth is sometime awfull.
JM KANG
JM KANG Feb 12, 2021 7:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Jacint Gabris   Can you teach us one?
Sebastian Startare
Sebastar Jan 13, 2021 10:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
🤏🤏
PAPPAERT ANDRE
PAPPAERT ANDRE Jul 25, 2019 5:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
De resultaten moeten zeer goed zijn anders zou men de resultaten niet vrij geven voor 6/8/19, Die zijn norrmaal voorzien voor 31/7/19;ofwel zijn er zeer goede resultaten in de onderzoeken?
PAPPAERT ANDRE
PAPPAERT ANDRE Jul 11, 2019 9:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
De ROE van Strongbridge Biopharma plc (NASDAQ: SBBP) 43% indrukwekkend?. 11/07/2019
Pavel Ermacov
Pavel Ermacov May 08, 2019 9:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
6 usd first target
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email